Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient.

Respir Med Res

Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France; Nantes University, Centre Hospitalier Universitaire Nantes, Department of Bichemistry, F-44000 Nantes, France.

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resmer.2024.101116DOI Listing

Publication Analysis

Top Keywords

concomitant alk
4
alk translocation
4
translocation egfr
4
egfr c797s
4
c797s mutation
4
mutation resistance
4
resistance mechanisms
4
mechanisms osimertinib
4
osimertinib egfr-mutant
4
egfr-mutant nsclc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!